Advertisement

Topics

Biocryst Announces Initiation Of ZENITH-1, A Clinical Trial To Evaluate BCX7353 As An Acute Treatment Of Hereditary Angioedema Attacks

20:00 EDT 1 Aug 2017 | BioSpace

  Life Sciences Jobs   ...

Original Article: Biocryst Announces Initiation Of ZENITH-1, A Clinical Trial To Evaluate BCX7353 As An Acute Treatment Of Hereditary Angioedema Attacks

NEXT ARTICLE

More From BioPortfolio on "Biocryst Announces Initiation Of ZENITH-1, A Clinical Trial To Evaluate BCX7353 As An Acute Treatment Of Hereditary Angioedema Attacks"

Quick Search
Advertisement